Access the full text.
Sign up today, get DeepDyve free for 14 days.
O. Beahrs, B. Pasternak (1969)
Cancer of the thyroid gland.Current problems in surgery
(1968)
Thyroid carcinoma: general considerations and follow-up data on 1181 cases
I. Hay, E. Bergstralh, J. Goellner, J. Ebersold, C. Grant (1993)
Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989.Surgery, 114 6
S. Grebe, I. Hay (1997)
The role of surgery in the management of differentiated thyroid cancerJournal of Endocrinological Investigation, 20
(1997)
TNM Classification of Malignant Tumours, International Union Against Cancer, 5th edition
O. Beahrs, L. Woolner (1959)
The treatment of papillary carcinoma of the thyroid gland.Surgery, gynecology & obstetrics, 108 1
I. Hay, C. Grant, E. Bergstralh, G. Thompson, J. Heerden, J. Goellner (1998)
Unilateral total lobectomy: is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma?Surgery, 124 6
P. Singer, D. Cooper, G. Daniels, P. Ladenson, F. Greenspan, E. Levy, L. Braverman, O. Clark, I. McDougall, K. Ain, S. Dorfman (1996)
Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. American Thyroid Association.Archives of internal medicine, 156 19
(1997)
AACE clinical practice guidelines for the management of thyroid carcinoma
E. Mazzaferri, Macp (2000)
Long-term outcome of patients with differentiated thyroid carcinoma: effect of therapy.Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 6 6
Brenda Nelson, L. Thompson (2004)
Papillary Thyroid CarcinomaENT Journal, 83
S. Hundahl, I. Fleming, A. Fremgen, H. Menck (1998)
A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985‐1995Cancer, 83
E. Kaplan, P. Meier (1958)
Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 53
Weiping Wang, H. Macapinlac, S. Larson, S. Yeh, T. Akhurst, R. Finn, J. Rosai, R. Robbins (1999)
[18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography localizes residual thyroid cancer in patients with negative diagnostic (131)I whole body scans and elevated serum thyroglobulin levels.The Journal of clinical endocrinology and metabolism, 84 7
C. Hedinger (1988)
Histological Typing of Thyroid Tumours
B. Cady (1997)
Our ames is true: How an old concept still hits the mark: or, risk group assignment points the arrow to rational therapy selection in differentiated thyroid cancerAmerican Journal of Surgery, 174
(1998)
Survey and analysis of thyroid carcinoma by the Japanese Society of Thyroid Surgery
(1997)
Thyroid cancer surgical practice guidelines: scope and format of guidelines
W. Mcconahey, I. Hay, L. Woolner, J. Heerden, W. Taylor (1986)
Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome.Mayo Clinic proceedings, 61 12
H. Mahorner (1966)
Cancer of the thyroid gland.Arizona medicine, 23 3
(1972)
Asymptotically efficient rank invariant procedures (with discussion)
(1999)
NCCN thyroid carcinoma practice guidelines
L. Sobin (1990)
Histological Typing of Thyroid TumoursHistopathology, 16
L. Wartofsky (2002)
Using baseline and recombinant human TSH-stimulated Tg measurements to manage thyroid cancer without diagnostic (131)I scanning.The Journal of clinical endocrinology and metabolism, 87 4
(1988)
Ultrasonographicguided biopsy of neck masses in the postoperative assessment of patients with thyroid malignancy
E. Mazzaferri, S. Jhiang (1994)
Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.The American journal of medicine, 97 5
E. Mazzaferri, R. Kloos (2001)
Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer.The Journal of clinical endocrinology and metabolism, 86 4
S. Grebe, I. Hay (1997)
Follicular cell-derived thyroid carcinomas.Cancer treatment and research, 89
I. Hay, C. Grant, J. Heerden, J. Goellner, J. Ebersold, E. Bergstralh (1992)
Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period.Surgery, 112 6
J. Sisson (1983)
Applying the radioactive eraser: I-131 to ablate normal thyroid tissue in patients from whom thyroid cancer has been resected.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 24 8
Joe Harrison (1892)
The National.Journal of Education, 36
It is uncertain whether more extensive primary surgery and increasing use of radioiodine remnant ablation (RRA) for papillary thyroid carcinoma (PTC) have resulted in improved rates of cause-specific mortality (CSM) and tumor recurrence (TR). Details of the initial presentation, therapy, and outcome of 2444 PTC patients consecutively treated during 1940–1999 were recorded in a computerized database. Patients were followed for more than 43,000 patient-years. The 25-year rates for CSM and TR were 5% and 14%, respectively. Temporal trends were analyzed for six decades. During the six decades, the proportion with initial MACIS (distant Metastasis, patient Age, Completeness of resection, local Invasion, and tumor Size) scores <6 were 77%, 82%, 84%, 86%, 85%, and 82%, respectively (p = 0.06). Lobectomy accounted for 70% of initial procedures during 1940–1949 and 22% during 1950–1959; during 1960–1999 bilateral lobar resection (BLR) accounted for 91% of surgeries (p <0.001). RRA after BLR was performed during 1950–1969 in 3% but increased to 18%, 57%, and 46% in successive decades (p <0.001). The 40-year rates for CSM and TR during 1940–1949 were significantly higher (p = 0.002) than during 1950–1999. During the last 50 years the 10-year CSM and TR rates for the 2286 cases did not significantly change with successive decades. Moreover, the 10-year rates for CSM and TR were not significantly improved during the last five decades of the study, either for the 1917 MACIS <6 patients or the 369 MACIS ? 6 patients. Increasing use of RRA has not apparently improved the already excellent outcome, achieved before 1970, in low risk (MACIS <6) PTC patients managed by near-total thyroidectomy and conservative nodal excision.
World Journal of Surgery – Wiley
Published: Aug 21, 2002
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.